Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease
Condition: Dry Eye Disease Interventions: Drug: Topical spironolactone ophthalmic solution, 0.005 mg/cc; Drug: Placebo Sponsor: Richard W Yee, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
Effect of Dapagliflozin on Secondary Mitral Regurgitation
Condition: Dilated Cardiomyopathy Interventions: Drug: Dapagliflozin Farxiga®; Drug: Ramipril Tritace®, Carvedilol Carvid®,and Spironolactone Aldactone® Sponsors: October 6 University; Beni-Suef University; National Heart Institute, Egypt Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2023 Category: Research Source Type: clinical trials
